Measurement of the renal clearance of drugs.
作者信息
Tucker G T
出版信息
Br J Clin Pharmacol. 1981 Dec;12(6):761-70. doi: 10.1111/j.1365-2125.1981.tb01304.x.
Abstract
摘要
相似文献
1
Measurement of the renal clearance of drugs.药物肾清除率的测定。
Br J Clin Pharmacol. 1981 Dec;12(6):761-70. doi: 10.1111/j.1365-2125.1981.tb01304.x.
2
Factors contributing to variability in drug pharmacokinetics. IV. Renal excretion.导致药物药代动力学变异性的因素。IV. 肾排泄。
J Clin Hosp Pharm. 1985 Dec;10(4):337-49. doi: 10.1111/j.1365-2710.1985.tb00932.x.
3
Pharmacokinetics and clearances related to renal processes.与肾脏过程相关的药代动力学和清除率。
Int J Clin Pharmacol Biopharm. 1978 Apr;16(4):155-72.
4
Dosage adjustment in renal insufficiency.肾功能不全时的剂量调整。
Br J Clin Pharmacol. 1982 Feb;13(2):145-53. doi: 10.1111/j.1365-2125.1982.tb01349.x.
5
Renal failure, drug pharmacokinetics and drug action.肾衰竭、药物药代动力学与药物作用
Clin Pharmacokinet. 1976;1(2):99-120. doi: 10.2165/00003088-197601020-00002.
6
Renal failure and the action of drugs.肾衰竭与药物的作用
Prog Biochem Pharmacol. 1974;9:206-20.
7
[Dosages of drugs in patients with kidney function disorders].[肾功能障碍患者的药物剂量]
Ned Tijdschr Geneeskd. 1991 Mar 30;135(13):547-51.
8
Rate constants of absorption versus physico-chemical parameters.吸收速率常数与物理化学参数的关系
Int J Clin Pharmacol Biopharm. 1978 Sep;16(9):413-6.
9
[Mechanisms of pharmacokinetic drug interactions. 2: Interaction mechanisms during absorption].[药物代谢动力学相互作用机制。2：吸收过程中的相互作用机制]
Pharmazie. 1984 Feb;39(2):129-36.
10
Multiple dose kinetics and drug dosage in patients with kidney disease.肾病患者的多剂量动力学与药物剂量
Acta Pharmacol Toxicol (Copenh). 1971;29 Suppl 3:211-24. doi: 10.1111/j.1600-0773.1971.tb03301.x.
引用本文的文献
1
Multiple-Dose Pharmacokinetics and Safety of Mitragynine, the Major Alkaloid of Kratom, in Rats.大鼠中 kratom 的主要生物碱——帽柱木碱的多剂量药代动力学及安全性研究
ACS Pharmacol Transl Sci. 2024 Jul 25;7(8):2452-2464. doi: 10.1021/acsptsci.4c00277. eCollection 2024 Aug 9.
2
Evaluation of 14 PFAS for permeability and organic anion transporter interactions: Implications for renal clearance in humans.评估 14 种全氟和多氟化合物对通透性和有机阴离子转运体相互作用的影响：对人体肾清除率的意义。
Chemosphere. 2024 Aug;361:142390. doi: 10.1016/j.chemosphere.2024.142390. Epub 2024 May 25.
3
Pharmacokinetics of tenofovir alafenamide, emtricitabine, and dolutegravir in a patient on peritoneal dialysis.替诺福韦艾拉酚胺、恩曲他滨和度鲁特韦在腹膜透析患者中的药代动力学。
AIDS Res Ther. 2024 May 21;21(1):34. doi: 10.1186/s12981-024-00616-5.
4
Pharmacokinetic Modeling of Bepotastine for Determination of Optimal Dosage Regimen in Pediatric Patients with Allergic Rhinitis or Urticaria.用于确定过敏性鼻炎或荨麻疹儿科患者最佳给药方案的倍他斯汀药代动力学建模
Pharmaceutics. 2024 Feb 27;16(3):334. doi: 10.3390/pharmaceutics16030334.
5
Interplay of Breast Cancer Resistance Protein (Bcrp/Abcg2), Sex, and Fed State in Oral Pharmacokinetic Variability of Furosemide in Rats.乳腺癌耐药蛋白（Bcrp/Abcg2）、性别和进食状态对呋塞米大鼠口服药代动力学变异性的相互作用
Pharmaceutics. 2023 Feb 6;15(2):542. doi: 10.3390/pharmaceutics15020542.
6
Albumin-Mediated Size Exclusion Chromatography: The Apparent Molecular Weight of PSMA Radioligands as Novel Parameter to Estimate Their Blood Clearance Kinetics.白蛋白介导的尺寸排阻色谱法：PSMA放射性配体的表观分子量作为估计其血液清除动力学的新参数。
Pharmaceuticals (Basel). 2022 Sep 19;15(9):1161. doi: 10.3390/ph15091161.
7
Plasma, urine and tissue concentrations of Flunixin and Meloxicam in Pigs.猪血浆、尿液和组织中氟尼辛和美洛昔康的浓度。
BMC Vet Res. 2020 Sep 16;16(1):340. doi: 10.1186/s12917-020-02556-4.
8
Application of Physiologically Based Pharmacokinetic Modeling to Predict Drug Exposure and Support Dosing Recommendations for Potential Drug-Drug Interactions or in Special Populations: An Example Using Tofacitinib.生理药代动力学模型在预测药物暴露和支持潜在药物相互作用或特殊人群给药建议中的应用：以托法替尼为例。
J Clin Pharmacol. 2020 Dec;60(12):1617-1628. doi: 10.1002/jcph.1679. Epub 2020 Jun 27.
9
The Influence of Drug Properties and Ontogeny of Transporters on Pediatric Renal Clearance through Glomerular Filtration and Active Secretion: a Simulation-Based Study.药物特性和转运体的个体发育对肾小球滤过和主动分泌途径的儿科肾清除率的影响：基于模拟的研究。
AAPS J. 2020 Jun 21;22(4):87. doi: 10.1208/s12248-020-00468-7.
10
Metformin disposition-A 40-year-old mystery.二甲双胍的处置——一个长达40年的谜团。
Br J Clin Pharmacol. 2020 Aug;86(8):1452-1453. doi: 10.1111/bcp.14320. Epub 2020 May 11.
本文引用的文献
1
DRUG MOVEMENT FROM THE ISOLATED URINARY BLADDER OF THE RABBIT.药物从兔离体膀胱的转运
Arch Int Pharmacodyn Ther. 1965 Mar;154:40-50.
2
INCONSTANCY OF RENAL CLEARANCE VALUES WITH CHANGING PLASMA CONCENTRATIONS.肾清除率值随血浆浓度变化而变化的不稳定性。
Nature. 1964 Jul 11;203:143-6. doi: 10.1038/203143a0.
3
RENAL TUBULAR MECHANISMS FOR EXCRETION OF ORGANIC ACIDS AND BASES.有机酸和碱排泄的肾小管机制
Am J Med. 1964 May;36:743-62. doi: 10.1016/0002-9343(64)90183-4.
4
Effects of tubular secretion and reabsorption on titration curves of tubular transport.肾小管分泌与重吸收对肾小管转运滴定曲线的影响。
Am J Physiol. 1961 Feb;200:393-9. doi: 10.1152/ajplegacy.1961.200.2.393.
5
Non-ionic diffusion and the excretion of weak acids and bases.非离子扩散与弱酸和弱碱的排泄
Am J Med. 1958 May;24(5):709-29. doi: 10.1016/0002-9343(58)90376-0.
6
Comparative serum concentration and excretion experiments with benzyl penicillin (G) and phenoxymethyl penicillin (V) on a single subject.在一名受试者身上进行的苄青霉素（G）和苯氧甲基青霉素（V）的血清浓度及排泄对比实验。
Antibiotic Med Clin Ther (New York). 1956 Jan;2(1):33-41.
7
Negligible excretion of unchanged ketoprofen, naproxen, and probenecid in urine.尿液中酮洛芬、萘普生和丙磺舒原形药物的排泄量可忽略不计。
J Pharm Sci. 1980 Nov;69(11):1254-7. doi: 10.1002/jps.2600691105.
8
Effect of exercise on renal clearance of atenolol.运动对阿替洛尔肾脏清除率的影响。
J Pharm Sci. 1980 Mar;69(3):344-5. doi: 10.1002/jps.2600690325.
9
Effect of plasma protein binding on renal clearance of drugs.血浆蛋白结合对药物肾清除率的影响。
J Pharm Sci. 1980 Apr;69(4):482-3. doi: 10.1002/jps.2600690437.
10
Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications.新生儿和婴儿的临床药代动力学。年龄相关差异及治疗意义。
Clin Pharmacokinet. 1980 Nov-Dec;5(6):485-527. doi: 10.2165/00003088-198005060-00001.
Zotero 插件